An Indian-origin researcher in Australia has received a grant of 3.3 million dollars for developing advanced manufacturing capabilities that focus on small-scale processing of materials produced from battery and consumer wastes.
Professor Veena Sahajwalla, founding Director of University of New South Wales (UNSW)'s Centre for Sustainable Materials Research & Technology (SMaRT), will lead a hub that aims to transform Australia's waste and resource recovery industry.
The project will deliver new information about high-temperature reactions of waste and selective synthesis techniques to transform waste into valuable materials and products, including metallic alloys, oxides and carbon, UNSW said in a statement.
The aim is for industry to adopt commercially viable technology and processes where low value or complex waste is reformed into high-value materials, creating jobs and environmental and social benefits, it said.
The hub is supported by a further 2.6 million dollars of industry contributions, according to the university.
Sahajwalla said it was vitally important for researchers to collaborate with industry and jointly tackle some of the society's big challenges, including solutions to waste and recycling issues.
"It is time to rethink attitudes towards all of the materials we design, produce, use and discard, to see them as renewable resources if we want to reduce our reliance on finite resources," Sahajwalla said in a statement.
"With this new work on battery waste, we can help create circular economies where waste materials can be reformed into new high-value materials to boost our manufacturing industry and supply chains," she said.
UNSW said it has has secured 8.3 million dollars in Australian Research Council (ARC) Industrial Transformation Research Program (ITRP) Hub grants for 2019.
Professor Rebecca Guy, an epidemiologist from the Kirby Institute and UNSW Medicine, will lead a hub awarded almost five million dollars to develop an integrated diagnostic and pharmaceutical approach to antibiotic resistance.
The hub will develop a world-first partnership between industry, researchers and stakeholders to tackle antimicrobial resistance.
The collaborative hub will focus on sexually transmitted microorganisms as a model of the wider problem of antimicrobial resistance.
"We plan to develop new molecular diagnostic technology and improve the processes for identifying potential new antibiotics," Guy said.
"The hub aims to connect the many complex facets of antimicrobial resistance, to provide a highly integrated diagnostic and pharmaceutical solution to the problem of antimicrobial resistance," she said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
